Basics
What Is CBD, and How Is It Different from THC?
Cannabidiol won't get you high, but it's not nothing either. Here's what CBD actually does, how it changes the effect of THC when the two are combined, and what the research does and doesn't support.
By The Crushed Desk · 1w ago · 5 min read
Photo: JoseLomah, CC BY-SA 4.0, via Wikimedia Commons
Key takeaways
- •CBD (cannabidiol) doesn't bind CB1 receptors the way THC does, so it isn't intoxicating on its own — you won't get high from CBD alone.
- •The FDA has approved exactly one CBD-based drug, Epidiolex, for two rare forms of childhood epilepsy. Most other wellness claims made about CBD are not backed by strong human clinical evidence yet.
- •CBD appears to moderate some of THC's effects when the two are used together, which is part of why the THC:CBD ratio on a label matters as much as either number alone.
- •Hemp-derived CBD (under 0.3% THC by dry weight) is federally legal in the U.S. under the 2018 Farm Bill, but state rules on cannabis-derived CBD products still vary, and product quality in the unregulated hemp-CBD market is inconsistent.
CBD, or cannabidiol, is the second-most-abundant cannabinoid in cannabis after THC, and the two get confused constantly because they come from the same plant and are often sold side by side. The key functional difference: CBD doesn't bind CB1 receptors the way THC does, so on its own it doesn't produce the euphoric high people associate with cannabis. That's the entire basis for hemp-derived CBD's legal status in the U.S. — the 2018 Farm Bill defines hemp as cannabis with less than 0.3% THC by dry weight, and CBD extracted from that hemp is treated very differently under federal law than cannabis-derived CBD from a higher-THC plant, even though the molecule itself is identical.
The research picture is much thinner than the marketing around CBD suggests. As of now, the FDA has approved exactly one CBD-based medication, Epidiolex, for two rare and severe forms of childhood epilepsy (Lennox-Gastaut and Dravet syndromes), based on randomized controlled trials that showed a real reduction in seizure frequency. Beyond that specific approval, claims that CBD treats anxiety, chronic pain, sleep issues, or inflammation are supported mostly by small studies, animal research, or anecdotal reporting — plausible directions for future research, but not yet the kind of large human trial evidence that would let a product legally claim to treat a condition.
Where CBD gets more interesting is in combination with THC. Some research and a lot of consistent user reporting suggest CBD can blunt certain THC effects — particularly anxiety and the intensity of the high — when the two are taken together, which is why some products are formulated with a deliberate THC:CBD ratio (1:1, 2:1, 20:1, and so on) rather than either cannabinoid alone. A high-CBD, low-THC product is a common recommendation for someone who wants to try cannabis without a strong psychoactive effect, though individual response still varies.
One practical caution: the unregulated hemp-derived CBD market (tinctures, gummies, and other products sold outside licensed cannabis dispensaries) has a well-documented quality-control problem. Independent lab testing of hemp-CBD products has repeatedly found significant numbers of them mislabeled — containing less CBD than claimed, more THC than the legal 0.3% threshold, or contaminants. Buying from a licensed dispensary with mandatory lab testing, or checking for a third-party Certificate of Analysis (COA) on a hemp product, meaningfully reduces that risk.
Strains in this story
This is general educational information, not medical advice. Effects vary by person, product, and dose — check local law, and talk to a doctor or licensed budtender for guidance specific to you.